SANTEN PHARMACEUTICAL CO.,LTD. (4536.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

14.8x

EV/EBITDA

8.2x

Market Cap

JPY 603.81B

MomentumView details →

1D Return

+0.19%

YTD Return

+12.52%

RSI (14)

38.6

ValuationView details →

P/E (Fwd)

14.8x

EV/EBITDA

8.2x

Market Cap

JPY 603.81B

RSI (14)

38.6

MomentumView details →

1D Return

+0.19%

YTD Return

+12.52%

ProfitabilityView details →

Gross Margin

58.21%

Net Margin

12.81%

EBITDA Margin

22.69%

ROE (TTM)

12.62%

ROA (TTM)

8.83%

Asset Turnover

0.71x

GrowthView details →

Revenue YoY

−2.79%

EPS YoY

+10.09%

FCF YoY

−32.45%

Revenue CAGR 3Y

+1.48%

EPS CAGR 3Y

+25.34%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

2.60x

Quick Ratio

1.87x

Div Yield

2.03%

Div Rate

JPY 38.00

Div Growth 1Y

+5.56%

Financials snapshotView financials →

Revenue (TTM)

291.62B

Net Income (TTM)

37.37B

Op. CF (TTM)

43.50B

Next earningsNov 5, 2026 →

Latest newsMore news →

Santen Pharmaceutical announced it will join the inaugural Global Summit for Eye Health as a High-Impact Partner, organized by IAPB in collaboration with WHO, to help shape the Global Eye Health Compact and unveil its global eye health commitment.30d ago

Similar companies

Sumitomo Pharma Co.,Ltd.4506.T ROHTO PHARMACEUTICAL CO.,LTD.4527.T HISAMITSU PHARMACEUTICAL CO.,INC.4530.T ONO PHARMACEUTICAL CO.,LTD.4528.T Kyowa Kirin Co.,Ltd.4151.T TSUMURA & CO.4540.T Find similar companies →

Latest newsMore news →

Santen Pharmaceutical announced it will join the inaugural Global Summit for Eye Health as a High-Impact Partner, organized by IAPB in collaboration with WHO, to help shape the Global Eye Health Compact and unveil its global eye health commitment.30d ago